Status:
UNKNOWN
PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Atherosclerosis
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of this study is to determine whether chemotherapy induces regression in atherosclerotic plaques in oncologic patients already undergoing PET FDG as part of their routine assessment.We wil...
Eligibility Criteria
Inclusion
- Women over the age of 65 diagnosed with metastatic breast cancer
- Men over the age of 65 diagnosed with lung cancer
Exclusion
- Patients under the age of 65
- Patients diagnosed with chronic inflammatory disease or chronic infection
- Patients taking steroids and NSAIDS on a regular basis
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00742352
Start Date
September 1 2008
Last Update
September 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239